Texas · House Bill 1680 · 89th Legislature, Regular Session

Relating to prior authorization for prescription drug benefits related to the prevention of human immunodeficiency virus infections.

  1. Introduced Dec 19, 2024
  2. In committee Mar 12, 2025
  3. Failed  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

Every action

14 steps, oldest first, as the legislature records them.

Show the 6 earlier steps
  1. HouseFiled
  2. HouseRead first time
  3. HouseReferred to Insurance
  4. CommitteeScheduled for public hearing on . . . · House Insurance
  5. CommitteeConsidered in public hearing · House Insurance
  6. CommitteeTestimony taken/registration(s) recorded in committee · House Insurance
  1. CommitteeLeft pending in committee · House Insurance
  2. CommitteeConsidered in formal meeting · House Insurance
  3. CommitteeFailed to receive affirmative vote in comm. · House Insurance
  4. CommitteeConsidered in formal meeting · House Insurance
  5. CommitteeReported favorably w/o amendment(s) · House Insurance
  6. HouseComte report filed with Committee Coordinator
  7. HouseCommittee report distributed
  8. HouseCommittee report sent to Calendars

Roll calls

1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.

Committee votes

DateWhereQuestionResult
May 9, 2025 House Insurance Insurance: Reported favorably w/o amendment(s) Passed 5–2

Sponsors

The member who introduced it.

From Texas's official records (ftp.legis.state.tx.us), checked Nov 1, 2026. Text links go to the official versions; LegiList does not copy bill text.